Table 3 |
|||
|
Correlation of P53, BCL-2 and Cyclin D1 expression in KIT positive GISTs with clinicopathological features |
|||
|
P53 |
BCL-2 |
Cyclin D1 |
|
|
|
|||
|
Tumor size |
0.01 |
0.408 |
0.243 |
|
Mitotic rate |
0.013 |
0.207 |
0.625 |
|
Risk of malignancy (Fletcher [10]) |
<0.0001 |
0.36 |
0.776 |
|
Risk of malignancy (Miettinen [11]) |
0.001 |
0.196 |
0.512 |
|
Nuclear atypia |
0.02 |
0.676 |
0.38 |
|
Proliferative activity (Ki67) |
0.01 |
0.794 |
0.352 |
|
Histological subtype |
0.002 |
0.391 |
0.782 |
|
Tumor site |
0.099 |
0.118 |
0.573 |
|
|
|||
|
Bold: significant probability |
|||
|
Pauser et al. BMC Cancer 2008 8:204 doi:10.1186/1471-2407-8-204 |
|||
